sr419
Small moleculeexperimental
Clinical trial activity
5 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 31, 2019 (NCT04021563)
Timeline
Indications
Mechanism of action
- Mu opioid receptorAGONIST
OPRM agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05357677 | Phase 2 | May 13, 2022 | Peking University, Shanghai Clinical Research Center Phase I Clinical Research Unit (SCRC-PCRU) |
| NCT05012761 | Phase 1 | Aug 24, 2021 | Shanghai Clinical Research Center Phase I Clinical Research Unit (SCRC-PCRU) |
| NCT04705077 | Phase 1 | Feb 2, 2021 | CMAX Clinical Research, SIMR |
| NCT04494815 | Phase 1 | Sep 18, 2020 | SIMR |
| NCT04021563 | Phase 1 | Jul 31, 2019 | Linear Clinical Research, SIMR, Syneos Health |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| SIMR | For profit | 3 | 3 | 1 | 2019 |
| Shanghai Clinical Research Center Phase I Clinical Research Unit (SCRC-PCRU) | Academic/Hospital | 2 | 2 | 2 | 2021 |
| CMAX Clinical Research | For profit | 1 | 0 | 1 | 2021 |
| Linear Clinical Research | For profit | 1 | 0 | 1 | 2019 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Syneos Health | For profit | 1 | 0 | 1 | 2019 |
6 organizations
Page 1 / 1